Our mission is to improve human health and well-being through innovative diagnostic tests and global partnerships. Omega is focused on providing specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within Health & Wellbeing and Global Health.
In Health & Wellbeing, through Cambridge Nutritional Sciences (CNS), we are empowering individuals to take control of their health by offering a range of food intolerance tests: Food Detective® (point-of-care), ELISA, Food Print® (Microarray) and CNS Lab Service.
Omega’s Global Health Division partnered with the Burnet Institute to deliver a worlds first in VISITECT® CD4, a rapid, convenient and affordable test for CD4 in people living with HIV. The test can be used in decentralised locations and is aimed at improving access to essential diagnostics in low- and middle-income countries.
Omega Diagnostics is part of the UK Rapid Test Consortium ("UK-RTC") to jointly develop and manufacture a COVID-19 point-of-care antibody test as part of the UK Government's five pillar national testing strategy for COVID-19.
